טוען...
Bendamustine for treatment of chronic lymphocytic leukemia
INTRODUCTION: Chronic lymphocytic leukemia (CLL) has an extended disease course in many patients. With a median age at diagnosis of 72 years, newer treatment options with less toxicity than standard nucleoside analogue-based regimens are needed. Historically, few therapy options are available once C...
שמור ב:
| Main Authors: | , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2012
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3467097/ https://ncbi.nlm.nih.gov/pubmed/22663160 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14656566.2012.693163 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|